AstraZeneca’s Imfinzi Gets Expanded EU Label With Approval for Gastric Cancer

3 weeks ago 22
The EU support of Imfinzi for early-stage gastric and gastroesophageal cancers expands the statement of 1 of the company’s top-selling oncology medicines.
Read Entire Article